AI-generated summary
This review describes depigmentation therapies for vitiligo, which are considered for patients with extensive depigmentation who do not respond to repigmentation treatments. The authors report that permanent topical agents, including monobenzyl ether of hydroquinone, 4-methoxyphenol and 88% phenol, along with physical methods such as cryotherapy and lasers, are used. They note that candidates should be carefully screened and that patient education is essential.
- Who or what was studied
- Patients with vitiligo affecting extensive body surface areas who are unresponsive to repigmentation therapies
- Limits stated in the abstract
- The abstract does not report study numbers, outcomes or efficacy data for the depigmentation therapies described.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.